MERIBANK BIOTECH CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.4 TWD | 0.00% |
|
-2.07% | -7.09% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 180M 5.56M | Sales 2023 | 234M 7.23M | Capitalization | 2.39B 73.84M |
|---|---|---|---|---|---|
| Net income 2022 | -102M -3.15M | Net income 2023 | -125M -3.86M | EV / Sales 2022 * | - |
| Net cash position 2022 | 162M 5M | Net cash position 2023 | 365M 11.28M | EV / Sales 2023 | 8.65 x |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
-19.1
x | Employees | 142 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.82% |
More Fundamentals
* Assessed data
| 1 week | -2.07% | ||
| Current month | -2.07% | ||
| 1 month | -5.09% | ||
| 3 months | +4.42% | ||
| 6 months | -8.76% | ||
| Current year | -7.09% |
1 week
33.75
36.30
1 month
33.7538.35
Current year
31.5541.50
1 year
27.8553.50
3 years
27.8553.50
5 years
27.8553.50
10 years
27.8553.50
| Managers | Title | Age | Since |
|---|---|---|---|
Shi Yang Wu
CEO | Chief Executive Officer | - | - |
Qi Ming Pan
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chang You Xuan
CHM | Chairman | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 35.4 | 0.00% | 56,359 |
| 24-05-07 | 35.4 | +3.06% | 142,470 |
| 24-05-06 | 34.35 | -1.58% | 159,199 |
| 24-05-03 | 34.9 | -3.46% | 143,478 |
| 24-05-02 | 36.15 | 0.00% | 328,495 |
End-of-day quote Taipei Exchange, May 07, 2024
More quotes
Meribank Biotech Co Ltd is a Taiwan-based company mainly engaged in the stem cell storage business. The Company is engaged in the provision of cord blood (hematopoietic stem cells) storage and application services, placenta and umbilical cord (mesenchymal stem cells) storage and application services, peripheral blood stem cell storage service and application service, and promotion of stem cell transplantation application, development of new stem cell processing technology and storage application services. The Company also develops allogeneic umbilical cord mesenchymal stem cell manufacturing and therapeutic applications.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.09% | 77.54M | |
| +16.28% | 81.04B | |
| -30.16% | 68.93B | |
| +9.65% | 29.59B | |
| +0.53% | 17.24B | |
| -10.90% | 16.99B | |
| -0.83% | 15.12B | |
| +5.81% | 13.09B | |
| +66.05% | 12B | |
| -2.20% | 11.94B |
- Stock Market
- Equities
- 4724 Stock